Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors

Alexander O. Pasternak, Jelmer Vroom, Neeltje A. Kootstra, Ferdinand W.N.M. Wit, Marijn de Bruin, Davide De Francesco, Margreet Bakker, Caroline A Sabin, Alan Winston, Jan M. Prins, Peter Reiss, Ben Berkhout on behalf of The Co-morBidity in Relation to Aids (COBRA) Collaboration
doi: https://doi.org/10.1101/2021.03.25.21254129

Data Availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Back to top
Posted August 08, 2021.
Download PDF
Data/Code
Email
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors
Alexander O. Pasternak, Jelmer Vroom, Neeltje A. Kootstra, Ferdinand W.N.M. Wit, Marijn de Bruin, Davide De Francesco, Margreet Bakker, Caroline A Sabin, Alan Winston, Jan M. Prins, Peter Reiss, Ben Berkhout
medRxiv 2021.03.25.21254129; doi: https://doi.org/10.1101/2021.03.25.21254129
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area